Publication
6/10/2001
Differences in the human and mouse amino-terminal leader peptides of ornithine transcarbamylase affect mitochondrial import and efficacy of adenoviral vectors.
Ye X, Zimmer KP, Brown R, Pabin C, Batshaw ML, Wilson JM, Robinson MB
Human Gene Therapy
Publication
10/01/2000
Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse.
Ye X, Robinson MB, Pabin C, Batshaw ML, Wilson JM
Gene Therapy
Publication
11/01/1999
Correction of ureagenesis after gene transfer in an animal model and after liver transplantation in humans with ornithine transcarbamylase deficiency.
Batshaw ML, Robinson MB, Ye X, Pabin C, Daikhin Y, Burton BK, Wilson JM, Yudkoff M
Pediatric Research
Publication
9/20/1998
Evaluating the potential of germ line transmission after intravenous administration of recombinant adenovirus in the C3H mouse.
Ye X, Gao GP, Pabin C, Raper SE, Wilson JM
Human Gene Therapy
Publication
4/01/1997
Adenovirus-mediated in vivo gene transfer rapidly protects ornithine transcarbamylase-deficient mice from an ammonium challenge.
Ye X, Robinson MB, Pabin C, Quinn T, Jawad A, Wilson JM, Batshaw ML
Pediatric Research
